Cyclacel Pharmaceuticals, Inc. (CYCC)

Cyclacel Pharmaceuticals Statistics

Total Valuation

CYCC has a market cap or net worth of $18.44 million. The enterprise value is $14.17 million.

Market Cap	18.44M
Enterprise Value	14.17M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CYCC has 2.24 million shares outstanding.

Current Share Class	2.24M
Shares Outstanding	2.24M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.39%
Owned by Insiders (%)	80.83%
Owned by Institutions (%)	0.99%
Float	314,657

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,843.80
Forward PS	361.53
PB Ratio	3.60
P/TBV Ratio	5.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1,417.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.77, with a Debt / Equity ratio of 0.00.

Current Ratio	5.77
Quick Ratio	5.63
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -276.80% and return on invested capital (ROIC) is -278.74%.

Return on Equity (ROE)	-276.80%
Return on Assets (ROA)	-102.83%
Return on Invested Capital (ROIC)	-278.74%
Return on Capital Employed (ROCE)	-284.48%
Revenue Per Employee	$833
Profits Per Employee	-$535,667
Employee Count	12
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, CYCC has paid $986,000 in taxes.

Income Tax	986,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.91% in the last 52 weeks. The beta is 0.09, so CYCC's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-96.91%
50-Day Moving Average	8.17
200-Day Moving Average	53.38
Relative Strength Index (RSI)	46.70
Average Volume (20 Days)	198,937

Short Selling Information

The latest short interest is 64,256, so 2.87% of the outstanding shares have been sold short.

Short Interest	64,256
Short Previous Month	101,016
Short % of Shares Out	2.87%
Short % of Float	20.42%
Short Ratio (days to cover)	0.01

Income Statement

In the last 12 months, CYCC had revenue of $10,000 and -$6.43 million in losses. Loss per share was -$4.06.

Revenue	10,000
Gross Profit	10,000
Operating Income	-10.36M
Pretax Income	-22.73M
Net Income	-6.43M
EBITDA	-10.36M
EBIT	-10.36M
Loss Per Share	-$4.06

Balance Sheet

The company has $4.28 million in cash and $10,000 in debt, giving a net cash position of $4.27 million or $1.90 per share.

Cash & Cash Equivalents	4.28M
Total Debt	10,000
Net Cash	4.27M
Net Cash Per Share	$1.90
Equity (Book Value)	3.63M
Book Value Per Share	2.29
Working Capital	3.62M

Cash Flow

Operating Cash Flow	-8.73M
Capital Expenditures	n/a
Free Cash Flow	-8.73M
FCF Per Share	-$3.90

Margins

Gross Margin	100.00%
Operating Margin	-103,580.00%
Pretax Margin	-54,220.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CYCC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-34.86%
FCF Yield	-47.33%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 7, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Jul 7, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

CYCC has an Altman Z-Score of -132.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-132.54
Piotroski F-Score	1